Welcome to HCV Advocate’s hepatitis blog. The intent of this blog is to keep our website audience up-to-date on information about hepatitis and to answer some of our web site and training audience questions. People are encouraged to submit questions and post comments.

For more information on how to use this blog, the HCV drug pipeline, and for more information on HCV clinical trials click here

Be sure to check out our other blogs: The HBV Advocate Blog and Hepatitis & Tattoos.


Alan Franciscus

Editor-in-Chief

HCV Advocate


Friday, February 6, 2015

Portugal: Gov't reaches deal for Hepatitis C drug

The Portuguese government has finally reached an agreement with an American pharmaceutical firm to bring an innovative drug to treat Hepatitis C to Portugal. 

The deal comes one year after the drug from Gilead Sciences reached Europe.

According to reports the Ministry of Health and national drugs watchdog Infarmed managed to negotiated a price that will enable more patients to be treated for less than €25,000 per treatment.

Newspaper Público reports that the plan is to treat between 10,000 and 12,000 patients with the new drug over the next three years.

Source: http://theportugalnews.com/news/govt-reaches-deal-for-hepatitis-c-drug/33932
Posted by at
Labels: , ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)